These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37535554)

  • 1. Physiological stress modulation of neural drug cue reactivity in cannabis use disorder.
    Macatee RJ; Preston TJ; Afshar K; Blaine SK; Schermitzler BS
    Psychol Addict Behav; 2023 Dec; 37(8):1039-1051. PubMed ID: 37535554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal stability of neurophysiological drug cue reactivity before and after acute stress in cannabis users: A test of incentive sensitization.
    Macatee RJ; Preston TJ; Afshar K; Blaine SK; Schermitzler B
    Drug Alcohol Depend; 2023 Jun; 247():109862. PubMed ID: 37062250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of a computerized distress intolerance intervention on electrocortical reactivity to cannabis and threat cues: A randomized controlled trial.
    Macatee RJ; Preston TJ; Afshar K; Schmidt NB; Cougle JR
    Psychol Addict Behav; 2022 Nov; 36(7):920-929. PubMed ID: 35129994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distress intolerance moderation of motivated attention to cannabis and negative stimuli after induced stress among cannabis users: an ERP study.
    Macatee RJ; Okey SA; Albanese BJ; Schmidt NB; Cougle JR
    Addict Biol; 2019 Jul; 24(4):717-729. PubMed ID: 29737034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decomposing the late positive potential to cannabis cues in regular cannabis users: A temporal-spatial principal component analysis.
    Preston TJ; Cougle JR; Schmidt NB; Macatee RJ
    Psychophysiology; 2024 Apr; 61(4):e14471. PubMed ID: 37937737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological sex and hormonal contraceptive associations with drug cue reactivity in cannabis use disorder.
    Macatee RJ; Cannon MJ; Schermitzler BS; Preston TJ; Afshar K
    J Psychiatr Res; 2024 Jun; 174():121-128. PubMed ID: 38626562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cue-elicited increases in incentive salience for marijuana: Craving, demand, and attentional bias.
    Metrik J; Aston ER; Kahler CW; Rohsenow DJ; McGeary JE; Knopik VS; MacKillop J
    Drug Alcohol Depend; 2016 Oct; 167():82-8. PubMed ID: 27515723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of a cannabis cue stimulus set.
    Macatee RJ; Carr M; Afshar K; Preston TJ
    Addict Behav; 2021 Jan; 112():106643. PubMed ID: 32977269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating a novel fMRI cannabis cue reactivity task in youth.
    Karoly HC; Schacht JP; Meredith LR; Jacobus J; Tapert SF; Gray KM; Squeglia LM
    Addict Behav; 2019 Feb; 89():20-28. PubMed ID: 30243035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distress intolerance moderation of neurophysiological markers of response inhibition after induced stress: Relations with cannabis use disorder.
    Macatee RJ; Albanese BJ; Crane NA; Okey SA; Cougle JR; Schmidt NB
    Psychol Addict Behav; 2018 Dec; 32(8):944-955. PubMed ID: 30407026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal course of mental health symptoms among veterans with and without cannabis use disorder.
    Livingston NA; Farmer SL; Mahoney CT; Marx BP; Keane TM
    Psychol Addict Behav; 2022 Mar; 36(2):131-143. PubMed ID: 34351175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing attentional bias and inhibitory control in cannabis use disorder using an eye-tracking paradigm with personalized stimuli.
    Yoon JH; San Miguel GG; Vincent JN; Suchting R; Haliwa I; Weaver MF; Schmitz JM; Lane SD
    Exp Clin Psychopharmacol; 2019 Dec; 27(6):578-587. PubMed ID: 30907601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of a brief distress intolerance intervention on acute stress modulation of response inhibition neurophysiology in cannabis use disorder.
    Afshar K; Cougle JR; Schmidt NB; Macatee RJ
    Addict Behav; 2023 Dec; 147():107811. PubMed ID: 37517377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FMRI activation to cannabis odor cues is altered in individuals at risk for a cannabis use disorder.
    Kleinhans NM; Sweigert J; Blake M; Douglass B; Doane B; Reitz F; Larimer M
    Brain Behav; 2020 Oct; 10(10):e01764. PubMed ID: 32862560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypothalamic-pituitary-adrenal axis reactivity to social stress and adolescent cannabis use: the TRAILS study.
    van Leeuwen AP; Creemers HE; Greaves-Lord K; Verhulst FC; Ormel J; Huizink AC
    Addiction; 2011 Aug; 106(8):1484-92. PubMed ID: 21631618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unraveling the role of cigarette use in neural cannabis cue reactivity in heavy cannabis users.
    Kuhns L; Kroon E; Filbey F; Cousijn J
    Addict Biol; 2021 May; 26(3):e12941. PubMed ID: 32761688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical conditions of primary care patients with documented cannabis use and cannabis use disorder in electronic health records: a case control study from an academic health system in a medical marijuana state.
    Padwa H; Huang D; Mooney L; Grella CE; Urada D; Bell DS; Bass B; Boustead AE
    Subst Abuse Treat Prev Policy; 2022 May; 17(1):36. PubMed ID: 35527269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex-related differences in subjective, but not neural, cue-elicited craving response in heavy cannabis users.
    Prashad S; Hammonds RP; Wiese AL; Milligan AL; Filbey FM
    Drug Alcohol Depend; 2020 Apr; 209():107931. PubMed ID: 32113057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated cognitive-behavioral therapy for comorbid cannabis use and anxiety disorders: The impact of severity of cannabis use.
    Buckner JD; Morris PE; Zvolensky MJ
    Exp Clin Psychopharmacol; 2021 Jun; 29(3):272-278. PubMed ID: 34264732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cue Reactivity in the Ventral Striatum Characterizes Heavy Cannabis Use, Whereas Reactivity in the Dorsal Striatum Mediates Dependent Use.
    Zhou X; Zimmermann K; Xin F; Zhao W; Derckx RT; Sassmannshausen A; Scheele D; Hurlemann R; Weber B; Kendrick KM; Becker B
    Biol Psychiatry Cogn Neurosci Neuroimaging; 2019 Aug; 4(8):751-762. PubMed ID: 31204249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.